Notable Mergers and Acquisitions of the Day 4/16 (XRX/CXP, FITB/FCTR, BSX/CRYO)
More News related to BSX
- Boston Scientific to Participate in Piper Jaffray Health Care Conference
- Boston Scientific (BSX) Receives 510(k) Clearance and CE Mark on WallFlex
- Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent
- UBS Upgrades Boston Scientific (BSX) to Buy
- Trading Review for Viking Systems Inc. Issued by Beacon Equity
More News related to CRYO
- Unusual 11 Mid-Day Movers 4/16: POZN, SORC, EXM, GRO Higher; TLB, HCSG, GLG, CDL Lower
- Notable Mergers and Acquisitions of the Day 4/16 (XRX/CXP, FITB/FCTR, BSX/CRYO)
- Boston Scientific To Acquire CryoCor (CYRO) for $1.35/Share
- CryoCor (CRYO) Receives 'Going Concern' From Auditor, Nasdaq Reviews Listing Eligibility
- CryoCor (CRYO) Misses Q4 EPS by 2c
More News related to CXP
- Corporate Express (CXP) Trading Halted
- Staples (SPLS) Receives EU Clearance to Acquire Corporate Express (CXP)
- Citi Reiterates 'Buy' Rating on Staples (SPLS)
- Notable Mergers and Acquisitions of the Day 6/3 (ICE, SPLS/CXP, MTZ)
- Staples (SPLS) Increases Offer for Corporate Express (CXP)
StreetInsider.com Notable Mergers and Acquisitions of the Day:
- Xerox Corporation (NYSE: XRX) and Corporate Express NV (NYSE: CXP) announced a definitive agreement for Xerox to acquire Veenman B.V., a subsidiary of Corporate Express, for approximately $68 million, essentially expanding Xerox’s reach into the small and mid-sized business market in the Netherlands.
- Fed OKs Fifth Third Bancorp (Nasdaq: FITB) Acquiring First Charter Corp (Nasdaq: FCTR) - Dow Jones
- Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (Nasdaq: CRYO) signed a definitive merger agreement, under which Boston Scientific will pay a cash purchase price of $1.35 per share of CryoCor, or approximately $17.6 million.
Shares of CRYO closed at $1.13 yesterday.
Related Categories
Special ReportsStocks Mentioned
-0.14
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
